We’re proud to celebrate our 10th Listing Anniversary with Euronext and the progress we’ve made over the past decade in translating immunology breakthroughs to innovative treatments. We remain committed to expanding our patient reach and advancing the rare disease treatment landscape. #TogetherWeDiscover
Today, we celebrated argenx's 10th listing anniversary. For the occasion, the three founders, Hans De Haard, Tim Van Hauwermeiren, and Torsten Dreier rang the market opening bell at our Brussels Euronext Office. argenx is a global immunology company developing novel antibody-based medicines for autoimmune diseases and cancer. They partner with academic researchers and advance multiple experimental medicines, with offices in Belgium, the United States, and Japan. The company is now revenue generating with its lead product. Since their listing in 2008, argenx has embarked on a remarkable journey, conquering new markets and continuously innovating. Today, I am proud to say that they are one of the most influential European biotech companies, being part of our BEL 20 and Euronext Tech Leaders indexes. I address my congratulations to argenx for their outstanding success and thanks all attendees of this bell ceremony. European Life Science Companies need significant amounts of financings. This can only happen with integrated capital markets. At Euronext we have made significant progress on this integration during the last decade with our seven listing venues, our four CSDs and our clearing house. Relentlessly, we must pursue the development the European capital markets union. We are on a mission ! #Euronext #Biotech #Innovation #argenX #EuronextTechLeaders #BEL20
Congratulations on your 10th Listing Anniversary! Here's to many more breakthroughs and advancements in rare disease treatments. #TogetherWeDiscover
Martin Hessing
2mo
Tim, Hans and Torsten congratulations and well done!
Managing Partner VVGB Advocaten- Chairman of the Board of Directors at argenx SE
2moProud and grateful for what we have accomplished to date and confident in our argonauts team for the future 👍👍👍